A new metastatic human tumor associated molecule, methods to detect both activated gene and protein and to interfere with gene expression

Details for Australian Patent Application No. 2009207926 (hide)

Owner HANSABIOMED OU

Inventors Fais, Stefano; Lozupone, Francesco

Agent A J Park

Pub. Number AU-A-2009207926

PCT Pub. Number WO2009/092385

Priority 61/062,453 25.01.08 US

Filing date 26 January 2009

Wipo publication date 30 July 2009

International Classifications

G01N 33/574 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for cancer

Event Publications

19 August 2010 PCT application entered the National Phase

  PCT publication WO2009/092385 Priority application(s): WO2009/092385

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009207927-A new method to measure and characterize microvesicles in the human body fluids

2009207923-Classification of individuals suffering from cardiovascular diseases according to survival prognoses as found by measuring the levels of biomarker YKL40